Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. (Q38430399)
Jump to navigation
Jump to search
scientific article published on May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. |
scientific article published on May 2014 |
Statements
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial (English)
Jennifer G Robinson
Bettina S Nedergaard
William J Rogers
Jonathan Fialkow
Joel M Neutel
David Ramstad
Ransi Somaratne
Jason C Legg
Patric Nelson
Scott M Wasserman
Robert Weiss
LAPLACE-2 Investigators